PT788511E - Hexapeptidos ciclicos com actividade antibiotica - Google Patents

Hexapeptidos ciclicos com actividade antibiotica

Info

Publication number
PT788511E
PT788511E PT95932935T PT95932935T PT788511E PT 788511 E PT788511 E PT 788511E PT 95932935 T PT95932935 T PT 95932935T PT 95932935 T PT95932935 T PT 95932935T PT 788511 E PT788511 E PT 788511E
Authority
PT
Portugal
Prior art keywords
hexapeptides
cycle
antibiotic activity
antibiotic
activity
Prior art date
Application number
PT95932935T
Other languages
English (en)
Portuguese (pt)
Inventor
Hisashi Takasugi
Masaki Tomishima
Akira Yamada
Hidenori Ohki
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26305774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT788511(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB9420425A external-priority patent/GB9420425D0/en
Priority claimed from GBGB9508745.8A external-priority patent/GB9508745D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of PT788511E publication Critical patent/PT788511E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT95932935T 1994-10-07 1995-09-29 Hexapeptidos ciclicos com actividade antibiotica PT788511E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9420425A GB9420425D0 (en) 1994-10-07 1994-10-07 New compound
GBGB9508745.8A GB9508745D0 (en) 1995-04-28 1995-04-28 New compound

Publications (1)

Publication Number Publication Date
PT788511E true PT788511E (pt) 2003-04-30

Family

ID=26305774

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95932935T PT788511E (pt) 1994-10-07 1995-09-29 Hexapeptidos ciclicos com actividade antibiotica

Country Status (26)

Country Link
US (2) US6107458A (cg-RX-API-DMAC7.html)
EP (1) EP0788511B1 (cg-RX-API-DMAC7.html)
JP (2) JP2897427B2 (cg-RX-API-DMAC7.html)
KR (1) KR100353303B1 (cg-RX-API-DMAC7.html)
CN (1) CN1203089C (cg-RX-API-DMAC7.html)
AR (1) AR041770A1 (cg-RX-API-DMAC7.html)
AT (1) ATE229541T1 (cg-RX-API-DMAC7.html)
AU (1) AU696949B2 (cg-RX-API-DMAC7.html)
BR (2) BR9504791B1 (cg-RX-API-DMAC7.html)
CA (1) CA2202058C (cg-RX-API-DMAC7.html)
DE (2) DE122008000025I2 (cg-RX-API-DMAC7.html)
DK (1) DK0788511T3 (cg-RX-API-DMAC7.html)
ES (1) ES2187575T3 (cg-RX-API-DMAC7.html)
FI (1) FI119988B (cg-RX-API-DMAC7.html)
FR (1) FR08C0028I2 (cg-RX-API-DMAC7.html)
HU (1) HU228151B1 (cg-RX-API-DMAC7.html)
IL (1) IL115484A (cg-RX-API-DMAC7.html)
LU (1) LU91452I2 (cg-RX-API-DMAC7.html)
MX (1) MX9702531A (cg-RX-API-DMAC7.html)
NL (1) NL300352I2 (cg-RX-API-DMAC7.html)
NO (2) NO328483B1 (cg-RX-API-DMAC7.html)
OA (1) OA10475A (cg-RX-API-DMAC7.html)
PT (1) PT788511E (cg-RX-API-DMAC7.html)
RU (1) RU2165423C2 (cg-RX-API-DMAC7.html)
TR (1) TR199501229A2 (cg-RX-API-DMAC7.html)
WO (1) WO1996011210A1 (cg-RX-API-DMAC7.html)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696084A (en) * 1996-08-16 1997-12-09 Abbott Laboratories Amino-lipopetide antifungal agents
AUPO371596A0 (en) * 1996-11-19 1996-12-12 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPO381496A0 (en) * 1996-11-25 1996-12-19 Fujisawa Pharmaceutical Co., Ltd. New compound
US6291680B1 (en) * 1997-06-18 2001-09-18 Fujisawa Pharmaceutical Co., Ltd. Production process
CA2320416A1 (en) * 1998-02-09 1999-08-12 Fujisawa Pharmaceutical Co., Ltd. New compound
AU756792B2 (en) * 1998-02-09 2003-01-23 Fujisawa Pharmaceutical Co., Ltd. New compound
ES2251976T3 (es) * 1999-02-11 2006-05-16 Emisphere Technologies, Inc. Compuestos y composiciones de oxadiazol para aportar agentes activos.
US7084279B1 (en) * 1999-02-11 2006-08-01 Emisphere Technologies Inc. Oxadiazole compounds and compositions for delivering active agents
AUPP999799A0 (en) * 1999-04-27 1999-05-20 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPQ066399A0 (en) * 1999-05-31 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
CA2380176A1 (en) 1999-07-27 2001-02-01 Aventis Pharma Deutschland Gmbh Novel cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical
AUPQ462399A0 (en) * 1999-12-13 2000-01-13 Fujisawa Pharmaceutical Co., Ltd. New use
TWI250992B (en) 2000-02-21 2006-03-11 Astellas Pharma Inc Polypeptide compounds for the prophylactic and/or therapeutic treatment of infectious diseases caused by pathogenic microorganisms
ES2191516B1 (es) * 2000-07-28 2005-01-01 Consejo Superior De Investigaciones Cientificas Antibioticos antifungicos de naturaleza peptidica inhibidores de la germinacion y el crecimiento de hongos fitopatogenos.
AUPQ938700A0 (en) * 2000-08-14 2000-09-07 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
ATE452637T1 (de) 2001-01-29 2010-01-15 Shionogi & Co Arzneipräparat, das als wirkstoff 5-methyl-1- phenyl-2-(1h)-pyridon enthält
JP2005053782A (ja) * 2001-08-31 2005-03-03 Fujisawa Pharmaceut Co Ltd 環状リポペプチド化合物の新規結晶
AU2003217676B2 (en) 2002-02-22 2009-06-11 Takeda Pharmaceutical Company Limited Active agent delivery systems and methods for protecting and administering active agents
US7199248B2 (en) 2002-08-08 2007-04-03 Astellas Pharma Inc. Process
AU2003903205A0 (en) * 2003-06-23 2003-07-10 Fujisawa Pharmaceutical Co., Ltd. New compound
WO2005018743A1 (en) * 2003-07-22 2005-03-03 Theravance, Inc. Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent
AU2004273029A1 (en) * 2003-09-05 2005-03-24 Merck & Co., Inc. Stationary phases and a purification process using the stationary phases
WO2005028438A1 (ja) * 2003-09-22 2005-03-31 Banyu Pharmaceutical Co., Ltd. 新規ピペリジン誘導体
US7476673B2 (en) * 2003-12-30 2009-01-13 Allergan, Inc. Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors
US20050261365A1 (en) * 2004-05-20 2005-11-24 The Scripps Research Institute Transthyretin stabilization
CN101084212A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为硬脂酰CoA去饱和酶介导剂的用途
BRPI0515482A (pt) 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos e seus usos como agentes terapêuticos
EP2289510A1 (en) 2004-09-20 2011-03-02 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
AR051092A1 (es) 2004-09-20 2006-12-20 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de la estearoil-coa
MX2007003332A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
TW200626155A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
JP5043668B2 (ja) 2004-09-20 2012-10-10 ゼノン・ファーマシューティカルズ・インコーポレイテッド 複素環誘導体および治療薬としてのそれらの使用
KR20070067165A (ko) * 2004-10-13 2007-06-27 피티씨 테라퓨틱스, 인크. 넌센스 변이 억제용 화합물, 및 이의 사용 방법
JP2009513563A (ja) 2005-06-03 2009-04-02 ゼノン・ファーマシューティカルズ・インコーポレイテッド ヒトのステアロイル−CoAデサチュラーゼ阻害剤としてのアミノチアゾール誘導体
WO2007043401A1 (ja) * 2005-10-07 2007-04-19 Kissei Pharmaceutical Co., Ltd. 含窒素複素環化合物およびそれを含有する医薬組成物
CN101516387B (zh) * 2006-07-26 2014-06-04 桑多斯股份公司 卡泊芬净制剂
US8853392B2 (en) 2007-06-03 2014-10-07 Vanderbilt University Benzamide mGluR5 positive allosteric modulators and methods of making and using same
PL2786992T3 (pl) 2007-08-13 2018-04-30 Monsanto Technology Llc Kompozycje i sposoby zwalczania nicieni
AU2008319977A1 (en) * 2007-10-29 2009-05-07 Astellas Pharma Inc. Polypeptide compound
US8034806B2 (en) 2007-11-02 2011-10-11 Vanderbilt University Bicyclic mGluR5 positive allosteric modulators and methods of making and using same
CA2729212C (en) * 2008-06-24 2014-04-01 Irm Llc Compounds and methods for modulating g protein-coupled receptors
US9394340B2 (en) 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
BR112013023531A2 (pt) * 2011-04-04 2016-12-06 Xellia Pharmaceuticals Aps processo de um único vaso para a fabricação de micafungina ou de um sal desta
BR112013026420A2 (pt) 2011-04-20 2020-11-03 Xellia Pharmaceuticals Aps método de produção de um sal de micafungina farmaceuticamente aceitável
CN102775476B (zh) 2011-05-12 2015-01-07 上海天伟生物制药有限公司 一种米卡芬净钠盐的制备方法
EP2709609B1 (en) 2011-05-17 2017-10-04 Shionogi & Co., Ltd. Heterocyclic compounds
EP2763971B1 (en) 2011-09-09 2016-06-08 Sandoz AG Preparation of micafungin intermediates
CN102659930B (zh) 2012-03-30 2014-04-23 上海天伟生物制药有限公司 一种高纯度环肽类物质的晶体及其制备方法和用途
CN102627689B (zh) 2012-03-30 2014-08-06 上海天伟生物制药有限公司 一种环肽类化合物的水合物及其制备方法和用途
CN102627688B (zh) 2012-03-30 2014-12-31 上海天伟生物制药有限公司 一种高纯度环肽化合物及其制备方法和用途
EP3150621A4 (en) * 2014-05-29 2017-12-27 Shanghai Techwell Biopharmaceutical Co., Ltd Composition of cyclic peptide compound, preparation method for same, and uses thereof
CN104861044B (zh) * 2014-05-29 2019-03-01 上海天伟生物制药有限公司 一种环肽类化合物的溶剂合物及其制备方法和用途
WO2016056023A2 (en) * 2014-10-07 2016-04-14 Alaparthi Lakshmi Prasad Intermediates and processes to prepare micafungin
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
FI3554474T3 (fi) 2016-12-16 2024-02-21 Baxter Int Mikafungiinikoostumuksia
EP3485873A1 (en) 2017-11-17 2019-05-22 Cadila Healthcare Limited Stable pharmaceutical injectable compositions of micafungin
CN113087775B (zh) * 2018-05-31 2022-07-08 杭州中美华东制药有限公司 米卡芬净钠新晶型ii及其制备方法
WO2020013116A1 (ja) * 2018-07-10 2020-01-16 京都薬品工業株式会社 Ptp-1b阻害剤およびその用途
CN110734408A (zh) * 2019-10-22 2020-01-31 重庆康乐制药有限公司 一种米卡芬净类衍生物侧链中间体的制备方法
CN115785226A (zh) * 2021-09-09 2023-03-14 上海天伟生物制药有限公司 一种棘白菌素药物杂质及其制备、纯化方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1574603A1 (ru) * 1988-08-11 1990-06-30 Ивановский Химико-Технологический Институт Способ получени мезо-тетраарилоктаметилпорфиринов
FI912873A7 (fi) * 1990-06-18 1991-12-19 Fujisawa Pharmaceutical Co Uusi polypeptidiyhdiste ja menetelmä sen valmistamiseksi
MY136593A (en) * 1992-03-19 2008-10-31 Lilly Co Eli Cyclic peptide antifungal agents and process for preparation thereof

Also Published As

Publication number Publication date
CA2202058C (en) 2007-11-06
FR08C0028I1 (cg-RX-API-DMAC7.html) 2008-08-15
CN1168675A (zh) 1997-12-24
LU91452I2 (fr) 2008-08-04
HUT77736A (hu) 1998-07-28
NO971544D0 (no) 1997-04-04
KR970707150A (ko) 1997-12-01
JPH10507174A (ja) 1998-07-14
NO971544L (no) 1997-06-04
FI971397L (fi) 1997-05-27
ES2187575T3 (es) 2003-06-16
IL115484A (en) 2000-07-16
KR100353303B1 (ko) 2003-01-15
NL300352I1 (nl) 2008-08-01
NO2010016I2 (no) 2011-10-17
EP0788511A1 (en) 1997-08-13
DE122008000025I1 (de) 2008-08-21
NO2010016I1 (no) 2010-08-16
DE122008000025I2 (de) 2011-02-17
JP3518665B2 (ja) 2004-04-12
ATE229541T1 (de) 2002-12-15
AU696949B2 (en) 1998-09-24
JP2897427B2 (ja) 1999-05-31
DE69529172D1 (de) 2003-01-23
US6107458A (en) 2000-08-22
JPH10324695A (ja) 1998-12-08
NO328483B1 (no) 2010-03-01
NL300352I2 (nl) 2008-11-03
EP0788511B1 (en) 2002-12-11
DK0788511T3 (da) 2003-03-31
BR9504791B1 (pt) 2010-10-05
CA2202058A1 (en) 1996-04-18
FI119988B (fi) 2009-05-29
BR9504791A (pt) 1996-10-22
US6265536B1 (en) 2001-07-24
CN1203089C (zh) 2005-05-25
TR199501229A2 (tr) 1996-07-21
MX9702531A (es) 1997-06-28
OA10475A (en) 2002-04-08
HK1004136A1 (en) 1998-11-20
IL115484A0 (en) 1996-01-19
RU2165423C2 (ru) 2001-04-20
DE69529172T2 (de) 2003-04-17
FR08C0028I2 (cg-RX-API-DMAC7.html) 2009-11-20
FI971397A0 (fi) 1997-04-04
HU228151B1 (en) 2012-12-28
AU3578095A (en) 1996-05-02
BRPI9504791B8 (pt) 2019-12-31
AR041770A1 (es) 2005-06-01
WO1996011210A1 (en) 1996-04-18

Similar Documents

Publication Publication Date Title
PT788511E (pt) Hexapeptidos ciclicos com actividade antibiotica
PT101950A (pt) 5-AMINO-4-ETILSULFINIL-1-ARILPIRAZóIS COM ACTIVIDADE PESTICIDA
LV11547A (lv) Makrolidi ar imunodepresantu aktivitati
DE69409436D1 (de) Multiaxiale garnstruktur
EP0858456A4 (en) TRITERPENES DERIVATIVES HAVING IMMUNODEPRESSIVE ACTIVITY
EE03401B1 (et) Antibiootilist aktiivsust omavad erütromütsiini A 9-O-oksiimi derivaadid
DE69516958D1 (de) Zeitschaltungsanordnung
EP0717286A3 (en) Consumption meter
NO934805D0 (no) Manifoldanordning
DE69414092D1 (de) Elastisches Doppelgestrick
NO950254L (no) Manifoldanordning
KR960010870A (ko) 항생제의 제조방법
NO981939D0 (no) Tiomorfinaner med neurobeskyttende aktivitet
KR950018692U (ko) 배기 기능을 갖는 깔때기
KR960005152U (ko) 세탁기
KR950033446U (ko) 내장판넬
NO932558L (no) Manifold-enhet
KR960008128U (ko) 세탁기
SK808U (sk) Škridla s prepážkou
KR950027906U (ko) 파스너의 체결구조
FI2331U1 (fi) Neulerakenne
KR970042021U (ko) 파스너의 체결구조
KR960011564U (ko) 이중 패스너
BR9401060A (pt) Estrutura de alvenaria com elementos modulares
KR970026620U (ko) 주머니를 갖는 양말